Shanghai Kaibao Pharmaceutical CO.,Ltd 300039.SZ Stock
Shanghai Kaibao Pharmaceutical CO.,Ltd Price Chart
Shanghai Kaibao Pharmaceutical CO.,Ltd 300039.SZ Financial and Trading Overview
Contents
| Shanghai Kaibao Pharmaceutical CO.,Ltd stock price | 5.85 CNY |
| Previous Close | 7.06 CNY |
| Open | 7.09 CNY |
| Bid | 7.37 CNY x 0 |
| Ask | 7.38 CNY x 0 |
| Day's Range | 7.05 - 7.58 CNY |
| 52 Week Range | 6.37 - 12.88 CNY |
| Volume | 79.44M CNY |
| Avg. Volume | 25.75M CNY |
| Market Cap | 7.72B CNY |
| Beta (5Y Monthly) | 0.18 |
| PE Ratio (TTM) | 28.384617 |
| EPS (TTM) | 0.26 CNY |
| Forward Dividend & Yield | 0.06 (0.85%) |
| Ex-Dividend Date | May 26, 2023 |
| 1y Target Est | N/A |
300039.SZ Valuation Measures
| Enterprise Value | 6.65B CNY |
| Trailing P/E | 28.384617 |
| Forward P/E | 28.384617 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.2400618 |
| Price/Book (mrq) | 2.0202572 |
| Enterprise Value/Revenue | 4.516 |
| Enterprise Value/EBITDA | 22.634 |
Trading Information
Shanghai Kaibao Pharmaceutical CO.,Ltd Stock Price History
| Beta (5Y Monthly) | 0.18 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 12.88 CNY |
| 52 Week Low | 6.37 CNY |
| 50-Day Moving Average | 7.01 CNY |
| 200-Day Moving Average | 7.26 CNY |
300039.SZ Share Statistics
| Avg. Volume (3 month) | 25.75M CNY |
| Avg. Daily Volume (10-Days) | 31.88M CNY |
| Shares Outstanding | 1.05B |
| Float | 623.78M |
| Short Ratio | N/A |
| % Held by Insiders | 41.50% |
| % Held by Institutions | 1.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.06 |
| Trailing Annual Dividend Yield | 0.84% |
| 5 Year Average Dividend Yield | 140.00% |
| Payout Ratio | 0.2339 |
| Last Split Factor | 13:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 18.21% |
| Operating Margin (ttm) | 20.65% |
| Gross Margin | 78.51% |
| EBITDA Margin | 19.95% |
Management Effectiveness
| Return on Assets (ttm) | 3.87% |
| Return on Equity (ttm) | 7.12% |
Income Statement
| Revenue (ttm) | 1.47B CNY |
| Revenue Per Share (ttm) | 1.41 CNY |
| Quarterly Revenue Growth (yoy) | 18.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 293.94M CNY |
| Net Income Avi to Common (ttm) | 268.32M CNY |
| Diluted EPS (ttm) | 0.26 |
| Quarterly Earnings Growth (yoy) | 69.79% |
Balance Sheet
| Total Cash (mrq) | 731.98M CNY |
| Total Cash Per Share (mrq) | 0.7 CNY |
| Total Debt (mrq) | 0 CNY |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.904 |
| Book Value Per Share (mrq) | 3.653 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 430.05M CNY |
| Levered Free Cash Flow (ttm) | 278.26M CNY |
Profile of Shanghai Kaibao Pharmaceutical CO.,Ltd
| Country | China |
| State | N/A |
| City | Shanghai |
| Address | No. 88 Chengpu Road |
| ZIP | 201401 |
| Phone | 86 21 3757 2030 |
| Website | https://www.xykb.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1380 |
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.
Q&A For Shanghai Kaibao Pharmaceutical CO.,Ltd Stock
What is a current 300039.SZ stock price?
Shanghai Kaibao Pharmaceutical CO.,Ltd 300039.SZ stock price today per share is 5.85 CNY.
How to purchase Shanghai Kaibao Pharmaceutical CO.,Ltd stock?
You can buy 300039.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Kaibao Pharmaceutical CO.,Ltd?
The stock symbol or ticker of Shanghai Kaibao Pharmaceutical CO.,Ltd is 300039.SZ.
Which industry does the Shanghai Kaibao Pharmaceutical CO.,Ltd company belong to?
The Shanghai Kaibao Pharmaceutical CO.,Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shanghai Kaibao Pharmaceutical CO.,Ltd have in circulation?
The max supply of Shanghai Kaibao Pharmaceutical CO.,Ltd shares is 1.05B.
What is Shanghai Kaibao Pharmaceutical CO.,Ltd Price to Earnings Ratio (PE Ratio)?
Shanghai Kaibao Pharmaceutical CO.,Ltd PE Ratio is 22.50000000 now.
What was Shanghai Kaibao Pharmaceutical CO.,Ltd earnings per share over the trailing 12 months (TTM)?
Shanghai Kaibao Pharmaceutical CO.,Ltd EPS is 0.26 CNY over the trailing 12 months.
Which sector does the Shanghai Kaibao Pharmaceutical CO.,Ltd company belong to?
The Shanghai Kaibao Pharmaceutical CO.,Ltd sector is Healthcare.